Han S. Chiu, Md work email
- Valid
- Valid
- Valid
Han S. Chiu, Md personal email
- Valid
- Valid
Han S. Chiu, Md phone numbers
Stanford M.D./Berkeley M.B.A. with extensive operating experience in building, growing and launching biotech/pharmaceutical companies. Skilled at investing and developing late-stage companies and founding and building early-stage companies. Experienced Venture Capitalist and deal maker (Forward Ventures, Novel Bioventures Advisors, CMX Capital). Expertise concentrated in pharmaceuticals, life science, healthcare and IT. Diverse experience developed through product management/product marketing, new product development and clinical development with big pharma companies (Novartis, Schering-Plough). Senior management operating positions include CEO, Chief Scientific Officer and business development at venture backed companies. Core competencies include:• Business Development • Strategic Marketing & Alliances• Product Marketing & Sales • Portfolio Analysis• New Product Development • Capital Fund Raising• Company and Product Due Diligence • Clinical Development• Pharmaceuticals/Biologics • Medical Devices• Health Care Services• Health Care ITInterested in careers in Venture Capital, Investments and Senior Management roles in operating life science companies including (CEO, CSO, VP Business Development, VP Marketing, and Senior Director level positions)Specialties: Venture Capital, Biotechnology, Entrenpreneurship, Marketing, Pharmaceuticals
Vavici Company
-
Founder And CeoVavici CompanySan Diego, Ca, Us
-
Founder & CeoVavici Company Nov 2016 - PresentVAVICI (vas-go, vie-life, chi-force; go-life-force) In the two decades since we've learned that obesity and diabetes are reversible, these once uncommon conditions are now the single biggest driver of healthcare costs. 40% of the population is obese, 50% have diabetes or pre-diabetes and 70% are overweight. When it comes to treating this and other chronic diseases the problem isn't knowing what to do, but how. Meanwhile, the typical drug/device moves into the mainstream at a breathtaking pace (30-60% penetration in less than 3 years). VAVICI will fix this problem by creating a path to market that enables every doctor to get the treatments that matter to the patients that need them. This means enabling an ecosystem of curative products, treatments, and services to move into the market just as quickly as drugs/devices do now. This allows doctors to create, lead, and empower communities of patients to work together to create the change we all seek.
-
Founder And Managing PartnerVavici Ventures Feb 2013 - PresentVavici Ventures is a Liberty Fund that partners with top medical institutions, payors, and doctors to build and launch (liberate) breakthrough healthcare models that have the potential to dramatically transform healthcare and save millions of lives. These are comprehensive programs that go well beyond symptom management, treating root cause paradigms capable of slowing, halting, and reversing chronic diseases. Many great technologies and approaches that we know work fail to have any significant market impact. This happens because they are not developed and implemented properly. Vavici enables primary care doctors to use these therapies by getting thought leaders, payors, and doctors to work together to build programs that make them commercially viable. Vavici's partners are not just Venture Capitalists they are Healthcare Venture Activists.
-
Advisor At Stanford'S Clinical Excellence Research CenterStanford University School Of Medicine Cerc Jul 2012 - Present
-
EirUcsd Connect 2008 - PresentEvaluated and advised new San Diego start-ups.
-
Founder And Managing PartnerCmx Capital, Llc (Formerly Novel Bioventures Advisors, Llc) Jan 2002 - PresentFounder and Managing Partner • Established and built a new life science venture fund that co-invested with many top funds.• Committed $20M in capital for seven major life science opportunities, including Aryx, Capnia, Predix, Omeros, Transmedics and Cellerant.• Negotiated term sheets, served on Boards and worked closely with CEOs and senior management teams.• Assumed operational roles within companies such as Bridgetech and Vavici (outlined below).Chief Scientific Officer VP Business Development, Bridgetech International • Identified and negotiated Asian licensing rights for company’s first four major compounds.• Presented and discussed business opportunities with partners in China, Hong Kong and Taiwan.Founder and Interim CEO, Vavici, LLC• Created the initial vision for a stem cell distribution channel.• Identified and established initial relationships with top academic centers including Stanford, UCSF and Johns Hopkins.
-
MemberPacific Arts Movement 2011 - 2015San Diego, California, Us -
MemberPacific Arts Movement 2011 - 2015San Diego, California, Us
-
Founder And CeoVavici, Llc Jan 2007 - Aug 2008• Created the initial vision for a stem cell distribution channel designed to validate and distribute all legitimate stem cell treatments and services.• Identified and established initial relationships with top academic centers including Stanford, UCSF and Johns Hopkins for potential stem cell and stem cell distribution collaborations.• Identified and established preliminary relationships with stem cell research and collection companies.• Initiated discussions for international licensing with Mexico and Bermuda.• Raised initial seed round of investment.
-
Chief Scientific Office & Vp Business DevelopmentBridgetech International Jan 2006 - Jan 2007Chief Scientific Officer VP Business Development, Bridgetech International • Identified and negotiated Asian licensing rights for company’s first four major compounds.• Presented and discussed business opportunities with partners in China, Hong Kong and Taiwan.• Set up preliminary discussions for manufacturing and GMP production in Taiwan.
-
Venture PartnerForward Ventures Feb 1998 - Aug 2001Venture Partner • Sourced, evaluated and negotiated new life science investment opportunities for Forward Ventures including Genicon Sciences, Conforma Therapeutics, Aitria, Converge, Trellis and MedicineNet.com.• Worked closely with senior management of operating companies and VCs in negotiating term sheets, establishing milestones and building syndicates.• Created and implemented effort to establish an e-health franchise through identifying and building e-health companies.• Active contributor in the raising of Forward IV, increasing the fund size from $42M to $250M.• Assumed operational roles in companies such as Aitria.Board Director: MedicineNet.com, Aitria Board Observer: Genicon Sciences, Arizeke, Nereus• Actively worked with management in evaluating business development opportunities, setting milestones, evaluating strategies and recruiting management.
-
Founder, Chairman And CeoAitria Jan 2000 - Jan 2001Formerly Doctors Online Medical ServicesFounder, Chairman, and Interim CEO of Aitria (Doctors Online Medical Services)• Created the initial vision for Aitria as a physician-patient communication company.• Identified and led negotiations resulting in the strategic merger of Aitria with Scibernet.• Led the management team as CEO and grew the company to over 20 employees.• Partnered with the leadership team in developing and presenting a business plan raising $2.3M in financing.• Led key business development initiatives resulting in a strategic alliance with MedAmerica and merger discussions with Medicity.• Recruited senior management team including chief operating and medical officers and my CEO replacement.
-
Board MemberMedicinenet 1999 - 2000
-
Senior Product ManagerSchering-Plough Research Institute Feb 1997 - May 1998Kenilworth, New Jersey, UsSenior Product Manager, Global Marketing, Biotech/Oncology Business Unit• Developed and led an international team of 30+ professionals in successfully launching Caelyx/Doxil in AIDS Kaposi’s Sarcoma.• Managed agency to create unifying brand imaging and messaging for global launch.• Set up a road show series of launch symposia for six major European affiliates.• Coordinated international and domestic marketing with Sequus (Caelyx/Doxil licensee with U.S. rights).• Developed Caelyx/Doxil protocol generation program supporting medical education and clinical trials.• Coordinated the development and dissemination of supportive pharmacoeconomic package.• Spearheaded Schering’s entry into solid tumors by coordinating Doxil development activities. -
Senior Market ManagerNovartis May 1992 - Feb 1997Basel, Baselstadt, Ch• Successfully launched Sandostatin in Acromegaly.• Led Sandimmune and Sandostatin product teams and exceeded sales budgets of $320M and $40M respectively.• Managed Lotrel, Sandimmune and Sandostatin annual marketing budgets of $20M, $10M and $5M million respectively including management of all promotional and educational agencies.• Turned around declining Sandostatin sales growth, effectively doubling sales growth to 24%.• Led cross-functional team in developing and implementing marketing and pre-marketing strategies.• Developed and implemented the Acromegaly Care Program with the American Association of Clinical Endocrinologists.• Served as part of the founding members of Novartis Oncology.• Established and trained Novartis’ first oncology field force.• Initiated successful out-licensing of Sandimmune for an ophthalmic application.New Product Manager, LescolClinical Research Medical Expert, Lamisil & PSC 833 -
Medical Fellow And Marketing ConsultantBd Biosciences Jan 1991 - Jun 1992Franklin Lakes, New Jersey, Us• Partnered with senior management in developing and presenting a strategic business opportunity model.• Developed marketing plans for launch of Advanced Cellular Biology Division. -
Research AssistantStanford University School Of Medicine Sep 1984 - Sep 1985Palo Alto, Ca, UsStudied Gibbon Ape Leukemia Virus insertions into the IL-2 gene in Dr. Jerry Crabtree's labReceived Medical Scholar's funding for this research -
Research AssistantNational Cancer Institute May 1983 - Aug 1984Bethesda, Md, UsSummer of 1983 Studied the retroviruses and the effect of caffeine on DNA in Dr. Stuart Arronson's LabSummer of 1984 Studied B Cells and cancer immunology in Dr. David Sach's Lab -
Research AssistantCornell University Sep 1983 - Jun 1984Ithaca, Ny, UsStudied retroviruses in Dr. Volker Vogt's lab
Han S. Chiu, Md Skills
Han S. Chiu, Md Education Details
-
University Of California, BerkeleyMarketing -
Stanford University School Of MedicinePediatrics
-
Cornell UniversityBiochemistry
-
The Johns Hopkins UniversityChemistry
Frequently Asked Questions about Han S. Chiu, Md
What company does Han S. Chiu, Md work for?
Han S. Chiu, Md works for Vavici Company
What is Han S. Chiu, Md's role at the current company?
Han S. Chiu, Md's current role is Founder and CEO.
What is Han S. Chiu, Md's email address?
Han S. Chiu, Md's email address is ha****@****ail.com
What is Han S. Chiu, Md's direct phone number?
Han S. Chiu, Md's direct phone number is +185873*****
What schools did Han S. Chiu, Md attend?
Han S. Chiu, Md attended University Of California, Berkeley, Stanford University School Of Medicine, Cornell University, The Johns Hopkins University.
What skills is Han S. Chiu, Md known for?
Han S. Chiu, Md has skills like Start Ups, Strategy, Biotechnology, Entrepreneurship, Venture Capital, Business Development, Lifesciences, Clinical Development, Mergers And Acquisitions, Medical Devices, Executive Management, Strategic Planning.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial